We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+4.83%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$46B
AUM Growth
+$2.18B
(+5%)
Cap. Flow
+$425M
Cap. Flow
% of AUM
0.92%
Top 10 Holdings %
Top 10 Hldgs %
15.17%
Holding
2,954
New
28
Increased
2,252
Reduced
604
Closed
50
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$128M |
| 2 |
Baker Hughes
BKR
|
+$26.7M |
| 3 |
IQVIA
IQV
|
+$14.5M |
| 4 |
Oneok
OKE
|
+$14.3M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$11.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$114M |
| 2 |
RAI
Reynolds American Inc
RAI
|
+$88.6M |
| 3 |
BHI
Baker Hughes
BHI
|
+$41.6M |
| 4 |
WFM
Whole Foods Market Inc
WFM
|
+$26.7M |
| 5 |
UnitedHealth
UNH
|
+$22.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.64% |
| 2 | Technology | 15.8% |
| 3 | Healthcare | 13.57% |
| 4 | Industrials | 10.87% |
| 5 | Consumer Discretionary | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
Globalstar
GSAT
$10.7B
| $851K | ﹤0.01% |
34,807
+427
| +1% | +$12.4K |
|
2052
Daktronics
DAKT
$955M
| $849K | ﹤0.01% |
80,336
+1,570
| +2% | +$15.2K |
|
|
KBAL
2053
DELISTED
Kimball International
KBAL
| $849K | ﹤0.01% |
42,953
+290
| +0.7% | +$4.95K |
|
2054
Quad
QUAD
$536M
| $848K | ﹤0.01% |
37,526
-426
| -1% | -$8.81K |
|
|
AVP
2055
DELISTED
Avon Products, Inc.
AVP
| $848K | ﹤0.01% |
363,993
-19,197
| -5% | -$56.9K |
|
2056
Fossil Group
FOSL
$293M
| $845K | ﹤0.01% |
90,531
+5,285
| +6% | +$49.6K |
|
2057
PTC Therapeutics
PTCT
$5.68B
| $842K | ﹤0.01% |
42,103
+3,335
| +9% | +$65.3K |
|
|
JAG
2058
DELISTED
Jagged Peak Energy Inc.
JAG
| $840K | ﹤0.01% |
61,521
+21,735
| +55% | +$284K |
|
2059
Astronics
ATRO
$3.43B
| $839K | ﹤0.01% |
38,908
+1,968
| +5% | +$40.2K |
|
2060
Matrix Service
MTRX
$326M
| $839K | ﹤0.01% |
55,203
+1,345
| +2% | +$15.3K |
|
|
SUP
2061
DELISTED
Superior Industries International
SUP
| $839K | ﹤0.01% |
50,414
+862
| +2% | +$14.7K |
|
|
RATE
2062
DELISTED
Bankrate Inc
RATE
| $836K | ﹤0.01% |
59,895
+320
| +0.5% | +$4.44K |
|
2063
Beazer Homes USA
BZH
$877M
| $832K | ﹤0.01% |
44,378
+310
| +0.7% | +$4.71K |
|
2064
Unitil
UTL
$970M
| $832K | ﹤0.01% |
16,816
+60
| +0.4% | +$2.99K |
|
2065
iShares Russell Mid-Cap Growth ETF
IWP
$19.8B
| $830K | ﹤0.01% |
+14,660
| New | +$804K |
|
|
TTSH
2066
DELISTED
Tile Shop Holdings
TTSH
| $830K | ﹤0.01% |
65,349
+2,350
| +4% | +$36.7K |
|
2067
iRhythm Holdings
IRTC
$3.85B
| $827K | ﹤0.01% |
15,939
+190
| +1% | +$8.6K |
|
2068
Heron Therapeutics
HRTX
$93.9M
| $826K | ﹤0.01% |
51,120
+490
| +1% | +$7.69K |
|
2069
Karyopharm Therapeutics
KPTI
$43.5M
| $826K | ﹤0.01% |
5,014
+27
| +0.5% | +$3.87K |
|
|
FLXN
2070
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $823K | ﹤0.01% |
34,047
-236
| -0.7% | -$5.55K |
|
2071
OFG Bancorp
OFG
$2.23B
| $821K | ﹤0.01% |
89,725
+1,166
| +1% | +$11.1K |
|
2072
AtriCure
ATRC
$1.92B
| $817K | ﹤0.01% |
36,516
+460
| +1% | +$10.4K |
|
2073
Central Garden & Pet Co
CENT
$2.69B
| $817K | ﹤0.01% |
26,305
+862
| +3% | +$23.8K |
|
2074
SolarEdge
SEDG
$2.51B
| $817K | ﹤0.01% |
+28,601
| New | +$721K |
|
2075
Vicor
VICR
$9.56B
| $817K | ﹤0.01% |
34,620
+490
| +1% | +$9.24K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2017 Portfolio in Review
As of Q3 2017, RhumbLine Advisers held 2,954 positions worth $46B, up 5% from $43.8B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q3 2017: portfolio turnover was 2.6%. RhumbLine Advisers opened 28 new positions and exited 50, leaving the 2,954-position portfolio largely intact.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.
- RhumbLine Advisers's largest Q3 2017 buy was Baker Hughes: 750,985 shares worth $27.5M.
- RhumbLine Advisers added most to DuPont de Nemours in Q3 2017, an estimated $128M increase.
- RhumbLine Advisers's biggest Q3 2017 reduction was UnitedHealth, cutting an estimated $22.8M.
- RhumbLine Advisers fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $114M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $46B portfolio in Q3 2017.
- RhumbLine Advisers opened 28 new positions and closed 50 in Q3 2017.
- RhumbLine Advisers's portfolio value rose 5% quarter-over-quarter to $46B.
Based on RhumbLine Advisers's 13F filing for Q3 2017, filed 6 Nov 2017.